Therefore, there is a need to further study the relative benefits of aerobic exercise and progressive resistance exercise in patients with Type 2 diabetes mellitus. The research question for this study was: Is progressive resistance training as effective as aerobic training of similar intensity and duration in terms of glycaemic, metabolic, anthropometric, and cardiovascular variables in sedentary older adults with Type 2 diabetes mellitus? A randomised trial was conducted with participants recruited from the Diabetes Centre of Singapore General Hospital. After baseline measurements of glycaemic, metabolic, anthropometric, and cardiovascular

profile were taken, participants were randomised to either an experimental (progressive resistance exercise) or a control (aerobic exercise) group, based on a computer-generated

assignment schedule XAV 939 that was kept by a physician not involved in the selection of the participants. Allocation was concealed by investigators making telephone contact with the physician who was the only person with access to the assigned schedule. All outcome measures were taken at the end of the 8-week intervention period by an independent assessor who was blinded to group allocation. Outcomes were measured between 36 and 48 hours after the last exercise session. All participants were specifically told not to discuss any aspect of their training with the assessor. The templates developed by the Research on Research group were used to facilitate communication with the statistician regarding data analysis Obeticholic Acid clinical trial and in the writing of the manuscript (Pietrobon et al 2004, Shah et al 2009). Patients were included if they were aged 50 years or above, had glycosylated haemoglobin (HbA1c) levels MTMR9 between 8% and 10% in the past month, and were able to walk continuously for at least 20 min and climb one flight of stairs unaided without stopping. They were also required to be sedentary, defined as reporting never having participated in a structured exercise program or recreational physical activity or sport. Subjects

were excluded if they had: uncontrolled diabetes mellitus with HbA1c more than 10% or if escalation of treatment of glycaemic control or dyslipidaemia was likely to be necessary over the 8-week trial period; congestive cardiac failure, unstable angina, or acute myocardial infarction within the last year; proliferative diabetic retinopathy; uncontrolled hypertension; advanced arthritis likely to limit mobility or participation in prescribed exercises; respiratory co-morbidities; significant proteinuria or chronic renal insufficiency; been prescribed a very low caloric diet (less than 1000 kcal/day) or drugs for the treatment of obesity; renal disease; or inability to monitor glucose level or to comply with the exercise program.